Literature DB >> 34617982

Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms.

Michael J Peluso1, Isaac J Thomas2, Sadie E Munter2, Steven G Deeks1, Timothy J Henrich2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34617982      PMCID： PMC9187313          DOI： 10.1093/cid/ciab890

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   20.999


× No keyword cloud information.
  5 in total

1.  Range of antinuclear antibodies in "healthy" individuals.

Authors:  E M Tan; T E Feltkamp; J S Smolen; B Butcher; R Dawkins; M J Fritzler; T Gordon; J A Hardin; J R Kalden; R G Lahita; R N Maini; J S McDougal; N F Rothfield; R J Smeenk; Y Takasaki; A Wiik; M R Wilson; J A Koziol
Journal:  Arthritis Rheum       Date:  1997-09

2.  SARS-CoV-2 infection as a trigger of autoimmune response.

Authors:  Maria C Sacchi; Stefania Tamiazzo; Paolo Stobbione; Lisa Agatea; Piera De Gaspari; Anna Stecca; Ernesto C Lauritano; Annalisa Roveta; Renato Tozzoli; Roberto Guaschino; Ramona Bonometti
Journal:  Clin Transl Sci       Date:  2021-01-21       Impact factor: 4.689

3.  Functional autoantibodies against G-protein coupled receptors in patients with persistent post-COVID-19 symptoms.

Authors:  Gerd Wallukat; Bettina Hohberger; Katrin Wenzel; Julia Fürst; Sara Schulze-Rothe; Anne Wallukat; Anne-Sophie Hönicke; Johannes Müller
Journal:  J Transl Autoimmun       Date:  2021-04-16

4.  Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.

Authors:  Antoine Guilmot; Sofia Maldonado Slootjes; Amina Sellimi; Maroussia Bronchain; Bernard Hanseeuw; Leila Belkhir; Jean Cyr Yombi; Julien De Greef; Lucie Pothen; Halil Yildiz; Thierry Duprez; Catherine Fillée; Ahalieyah Anantharajah; Antoine Capes; Philippe Hantson; Philippe Jacquerye; Jean-Marc Raymackers; Frederic London; Souraya El Sankari; Adrian Ivanoiu; Pietro Maggi; Vincent van Pesch
Journal:  J Neurol       Date:  2020-07-30       Impact factor: 4.849

5.  Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study.

Authors:  Jessica Seeßle; Tim Waterboer; Theresa Hippchen; Julia Simon; Marietta Kirchner; Adeline Lim; Barbara Müller; Uta Merle
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079
  5 in total
  7 in total

1.  Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.

Authors:  Michael J Peluso; Hannah M Sans; Carrie A Forman; Alyssa N Nylander; Hsi-En Ho; Scott Lu; Sarah A Goldberg; Rebecca Hoh; Viva Tai; Sadie E Munter; Ahmed Chenna; Brandon C Yee; John W Winslow; Christos J Petropoulos; Jeffrey N Martin; J D Kelly; Matthew S Durstenfeld; Priscilla Y Hsue; Peter W Hunt; Meredith Greene; Felicia C Chow; Joanna Hellmuth; Timothy J Henrich; David V Glidden; Steven G Deeks
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-06-14

2.  Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation.

Authors:  Leonardo Tamariz; Elizabeth Bast; Maria Abad; Nancy Klimas; Pat Caralis; Ana Palacio
Journal:  J Med Virol       Date:  2022-04-09       Impact factor: 20.693

Review 3.  Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.

Authors:  Michael J Peluso; Joanna Donatelli; Timothy J Henrich
Journal:  Transl Res       Date:  2021-11-12       Impact factor: 7.012

4.  Immunologic phenotype of patients with long-COVID syndrome of 1-year duration.

Authors:  Javier García-Abellán; Marta Fernández; Sergio Padilla; José Alberto García; Vanesa Agulló; Valle Lozano; Nuria Ena; Lidia García-Sánchez; Félix Gutiérrez; Mar Masiá
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

Review 5.  Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches.

Authors:  Jasimuddin Ahamed; Jeffrey Laurence
Journal:  J Clin Invest       Date:  2022-08-01       Impact factor: 19.456

6.  Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.

Authors:  Michael J Peluso; Tyler-Marie Deveau; Sadie E Munter; Dylan Ryder; Amanda Buck; Gabriele Beck-Engeser; Fay Chan; Scott Lu; Sarah A Goldberg; Rebecca Hoh; Viva Tai; Leonel Torres; Nikita S Iyer; Monika Deswal; Lynn H Ngo; Melissa Buitrago; Antonio Rodriguez; Jessica Y Chen; Brandon C Yee; Ahmed Chenna; John W Winslow; Christos J Petropoulos; Amelia N Deitchman; Joanna Hellmuth; Matthew A Spinelli; Matthew S Durstenfeld; Priscilla Y Hsue; J Daniel Kelly; Jeffrey N Martin; Steven G Deeks; Peter W Hunt; Timothy J Henrich
Journal:  medRxiv       Date:  2022-07-22

7.  Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement.

Authors:  Michael J Peluso; J Daniel Kelly; Scott Lu; Sarah A Goldberg; Michelle C Davidson; Sujata Mathur; Matthew S Durstenfeld; Matthew A Spinelli; Rebecca Hoh; Viva Tai; Emily A Fehrman; Leonel Torres; Yanel Hernandez; Meghann C Williams; Mireya I Arreguin; Lynn H Ngo; Monika Deswal; Sadie E Munter; Enrique O Martinez; Khamal A Anglin; Mariela D Romero; Jacqueline Tavs; Paulina R Rugart; Jessica Y Chen; Hannah M Sans; Victoria W Murray; Payton K Ellis; Kevin C Donohue; Jonathan A Massachi; Jacob O Weiss; Irum Mehdi; Jesus Pineda-Ramirez; Alex F Tang; Megan A Wenger; Melissa T Assenzio; Yan Yuan; Melissa R Krone; Rachel L Rutishauser; Isabel Rodriguez-Barraquer; Bryan Greenhouse; John A Sauceda; Monica Gandhi; Aaron Wolfe Scheffler; Priscilla Y Hsue; Timothy J Henrich; Steven G Deeks; Jeffrey N Martin
Journal:  Open Forum Infect Dis       Date:  2021-12-21       Impact factor: 4.423
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.